Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Price:
1 052.95 INR
-0.52%
Market Closed
Updated:
May 29, 2024
Zydus Lifesciences Ltd
Cash from Investing Activities
|
Zydus Lifesciences Ltd
Cash from Investing Activities Peer Comparison
Comparables:
DRREDDY
CIPLA
SUNPHARMA
T
TORNTPHARM
M
MANKIND
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Cash from Investing Activities
-₹14.8B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Cash from Investing Activities
-₹40.3B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Cash from Investing Activities
-₹29.9B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Cash from Investing Activities
-₹55.9B
|
CAGR 3-Years
-61%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Cash from Investing Activities
-₹20.1B
|
CAGR 3-Years
-63%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
M
|
Mankind Pharma Ltd
NSE:MANKIND
|
Cash from Investing Activities
-₹20.8B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Zydus Lifesciences Ltd's Cash from Investing Activities?
Cash from Investing Activities
-14.8B
INR
-14.8B
INR
Based on the financial report for Mar 31, 2024, Zydus Lifesciences Ltd's Cash from Investing Activities amounts to -14.8B INR.
What is Zydus Lifesciences Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
-27%
-27%
The average annual Cash from Investing Activities growth rates for Zydus Lifesciences Ltd have been -27% over the past three years .
You don't have any saved screeners yet
